BioSpace News Archive

Alliance Design Development Group (ADDG), an assistive human augmentation technology company known for creating SelectFlex® adjustable arch orthotics, donates 10% of sales to Global Giving and becomes ergonomic vendor for Roche subsidiary Genentech.

Syndax Pharmaceuticals, Inc. announced three presentations at the upcoming 2020 American Association for Cancer Research Virtual Annual Meeting being held April 27 - 28, 2020.

Alnylam Pharmaceuticals, Inc. (Nasdaq: ALNY), the leading RNAi therapeutics company, announced today that the U.S. Food and Drug Administration (FDA) has granted Fast Track designation to vutrisiran, an investigational therapeutic for the treatment of the polyneuropathy of hereditary transthyretin-mediated (hATTR) amyloidosis in adults. According to the FDA, Fast Track designation is designed to facilitate the develo

Vaccines create significant value for healthcare systems by preventing infectious disease; despite this, the vast majority of viruses do not have commercial vaccines available, representing a large opportunity

Agtech innovator well positioned to bring needed sustainable solutions to market; investors include Spruce Capital Partners/MLS, 1955 Capital, Phoenix Venture Partners, Cavallo Ventures, Davinia Investment Ltd., and Alexandria Ventures

Can-Fite BioPharma Ltd. announced it will conduct a conference call with investors to review the results of its Phase II exploratory NAFLD/NASH study with Namodenoson which achieved its primary and secondary efficacy endpoints, while showing continued safety.

Theratechnologies Inc., a commercial-stage biopharmaceutical company, announced its financial results for the first quarter ended February 29, 2020.

Immutep Limited announced that interim Phase II TACTI-002 clinical data has been selected for a poster short talk presentation as part of the high-impact paper presentation program at the American Association for Cancer Research Virtual Annual Meeting, scheduled for 27 and 28 April.

Multiple factors are leading to increase in demand for ventilators. Some of the include increased focus on intensive care and rapidly rising population of geriatric population worldwide.

Caris Life Sciences®, a leading innovator in molecular science focused on fulfilling the promise of precision medicine, announced Chadi Nabhan, MD, MBA, FACP has been appointed Chairman of its Precision Oncology Alliance™.